Cargando…

Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study

The infant gut microbiota affects childhood health. This pioneer microbiota may be vulnerable to antibiotic exposures, but could be supported by prebiotic oligosaccharides found in breast milk and some infant formulas. We sought to characterize the effects of several exposures on the neonatal gut mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnett, D.J.M, Endika, M.F, Klostermann, C.E, Gu, F, Thijs, C, Nauta, A, Schols, H.A, Smidt, H, Arts, I.C.W, Penders, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833409/
https://www.ncbi.nlm.nih.gov/pubmed/36617628
http://dx.doi.org/10.1080/19490976.2022.2164152
_version_ 1784868233713549312
author Barnett, D.J.M
Endika, M.F
Klostermann, C.E
Gu, F
Thijs, C
Nauta, A
Schols, H.A
Smidt, H
Arts, I.C.W
Penders, J
author_facet Barnett, D.J.M
Endika, M.F
Klostermann, C.E
Gu, F
Thijs, C
Nauta, A
Schols, H.A
Smidt, H
Arts, I.C.W
Penders, J
author_sort Barnett, D.J.M
collection PubMed
description The infant gut microbiota affects childhood health. This pioneer microbiota may be vulnerable to antibiotic exposures, but could be supported by prebiotic oligosaccharides found in breast milk and some infant formulas. We sought to characterize the effects of several exposures on the neonatal gut microbiota, including human milk oligosaccharides (HMOs), galacto-oligosaccharides (GOS), and infant/maternal antimicrobial exposures. We profiled the stool microbiota of 1023 one-month-old infants from the KOALA Birth Cohort using 16S rRNA gene amplicon sequencing. We quantified 15 HMOs in breast milk from the mothers of 220 infants, using high-performance liquid chromatography-mass spectrometry. Both breastfeeding and antibiotic exposure decreased gut microbial diversity, but each was associated with contrasting shifts in microbiota composition. Other factors associated with microbiota composition included C-section, homebirth, siblings, and exposure to animals. Neither infant exposure to oral antifungals nor maternal exposure to antibiotics during pregnancy were associated with infant microbiota composition. Four distinct groups of breast milk HMO compositions were evident, corresponding to maternal Secretor status and Lewis group combinations defined by the presence/absence of certain fucosylated HMOs. However, we found the strongest evidence for microbiota associations between two non-fucosylated HMOs: 6’-sialyllactose (6’-SL) and lacto-N-hexaose (LNH), which were associated with lower and higher relative abundances of Bifidobacterium, respectively. Among 111 exclusively formula-fed infants, the GOS-supplemented formula was associated with a lower relative abundance of Clostridium perfringens. In conclusion, the gut microbiota is sensitive to some prebiotic and antibiotic exposures during early infancy and understanding their effects could inform future strategies for safeguarding a health-promoting infant gut microbiota.
format Online
Article
Text
id pubmed-9833409
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98334092023-01-12 Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study Barnett, D.J.M Endika, M.F Klostermann, C.E Gu, F Thijs, C Nauta, A Schols, H.A Smidt, H Arts, I.C.W Penders, J Gut Microbes Research Paper The infant gut microbiota affects childhood health. This pioneer microbiota may be vulnerable to antibiotic exposures, but could be supported by prebiotic oligosaccharides found in breast milk and some infant formulas. We sought to characterize the effects of several exposures on the neonatal gut microbiota, including human milk oligosaccharides (HMOs), galacto-oligosaccharides (GOS), and infant/maternal antimicrobial exposures. We profiled the stool microbiota of 1023 one-month-old infants from the KOALA Birth Cohort using 16S rRNA gene amplicon sequencing. We quantified 15 HMOs in breast milk from the mothers of 220 infants, using high-performance liquid chromatography-mass spectrometry. Both breastfeeding and antibiotic exposure decreased gut microbial diversity, but each was associated with contrasting shifts in microbiota composition. Other factors associated with microbiota composition included C-section, homebirth, siblings, and exposure to animals. Neither infant exposure to oral antifungals nor maternal exposure to antibiotics during pregnancy were associated with infant microbiota composition. Four distinct groups of breast milk HMO compositions were evident, corresponding to maternal Secretor status and Lewis group combinations defined by the presence/absence of certain fucosylated HMOs. However, we found the strongest evidence for microbiota associations between two non-fucosylated HMOs: 6’-sialyllactose (6’-SL) and lacto-N-hexaose (LNH), which were associated with lower and higher relative abundances of Bifidobacterium, respectively. Among 111 exclusively formula-fed infants, the GOS-supplemented formula was associated with a lower relative abundance of Clostridium perfringens. In conclusion, the gut microbiota is sensitive to some prebiotic and antibiotic exposures during early infancy and understanding their effects could inform future strategies for safeguarding a health-promoting infant gut microbiota. Taylor & Francis 2023-01-08 /pmc/articles/PMC9833409/ /pubmed/36617628 http://dx.doi.org/10.1080/19490976.2022.2164152 Text en © 2023 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Barnett, D.J.M
Endika, M.F
Klostermann, C.E
Gu, F
Thijs, C
Nauta, A
Schols, H.A
Smidt, H
Arts, I.C.W
Penders, J
Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title_full Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title_fullStr Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title_full_unstemmed Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title_short Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study
title_sort human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the koala birth cohort study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833409/
https://www.ncbi.nlm.nih.gov/pubmed/36617628
http://dx.doi.org/10.1080/19490976.2022.2164152
work_keys_str_mv AT barnettdjm humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT endikamf humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT klostermannce humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT guf humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT thijsc humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT nautaa humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT scholsha humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT smidth humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT artsicw humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy
AT pendersj humanmilkoligosaccharidesantimicrobialdrugsandthegutmicrobiotaoftermneonatesobservationsfromthekoalabirthcohortstudy